Article
Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.
Neurology - 13 Jul 1999
Caselli R J, Graff-Radford N R, Reiman E M, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau S N
Abstract excerpt
OBJECTIVE: To determine, in a cross-sectional evaluation of nondemented individuals, if age-related memory decline is influenced by apolipoprotein E (apoE) genotype. BACKGROUND: The apoE-4 allele is an important risk factor for AD. PET in cognitively normal apoE-4 carriers (mean age, 56 years) shows reduced cerebral metabolism suggestive of very early AD that precedes clinically evident memory loss or MRI-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
